Vital

When the medication isn't working

Mounjaro Not Working? Dose Steps, Timing, Next Steps

If Mounjaro is not working for your blood sugar or weight, the dose step, the time since you started, and practical issues like missed doses or storage are the first things to check.

Last reviewed

The Vital angle

Vital records each Mounjaro dose with the date, amount, and injection site, so the time spent on each 2.5 mg step and any missed weeks are clear. Blood glucose and weight from Apple Health appear next to that dose history, and symptom tags show whether side effects held back a step.

Mounjaro (tirzepatide) has strong trial results, so a slow start can feel like a personal failure. In most cases, "Mounjaro not working" turns out to mean "still early," "still on a low dose," or "measured in a way that hides the trend." Sometimes it does mean a weaker response, and then the next step is a conversation with your prescriber.

This guide explains what the Mounjaro label says, how to check the common causes, and what information makes that conversation useful. It does not tell you to change a dose. Your prescriber makes those decisions.

What Mounjaro is approved for

Mounjaro is approved for type 2 diabetes. The label lists two uses: to improve blood sugar control alongside diet and exercise in adults and children 10 years and older, and to lower the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk.

The same medicine, tirzepatide, is sold as Zepbound for weight management and sleep apnea. Weight loss on Mounjaro is common and well documented, but if weight is your main goal, the right product and dose is a prescriber question. See Zepbound not working if that is your situation.

Tirzepatide acts on two hormone receptors, GIP and GLP-1. That is why people often expect more from it than from semaglutide. In the label's head-to-head trial, it did lower A1C and weight more on average. Averages still hide a wide range of individual results.

The dose ladder takes months

The label sets this schedule:

  1. Start at 2.5 mg once a week.
  2. If more blood sugar control is needed, increase by 2.5 mg after at least 4 weeks on the current dose.
  3. The maximum adult dose is 15 mg once a week.

So the steps are 2.5, 5, 7.5, 10, 12.5, and 15 mg. If your prescriber moves you up every 4 weeks, reaching 15 mg takes about 20 weeks. Many people stay longer on a step because of side effects or because their blood sugar goal is met at a lower dose.

The 2.5 mg dose is mainly there to help your stomach adjust. Judging Mounjaro on the first month is judging it on the lowest dose. For what the first weeks on these drugs usually feel like, see GLP-1 not working in the first month.

What results the label reports

In a 40-week trial of Mounjaro used alone in adults with type 2 diabetes:

  • A1C fell by about 1.7 to 1.8 points on 5 mg, 10 mg, and 15 mg, compared with 0.1 points on placebo.
  • Weight fell by about 6.3 kg on 5 mg, 7.0 kg on 10 mg, and 7.8 kg on 15 mg, compared with 1.0 kg on placebo.

In a 40-week trial against semaglutide 1 mg, both added to metformin, Mounjaro lowered A1C by 2.0 to 2.3 points and weight by 7.6 to 11.2 kg, depending on dose. Semaglutide 1 mg lowered A1C by 1.9 points and weight by 5.7 kg.

Two things follow from these numbers. First, blood sugar results were similar across the higher doses, so a dose increase does not always mean a much bigger A1C drop. Second, weight loss grew with dose, so a person on 5 mg should not expect the 15 mg weight result.

Checklist when blood sugar is not improving

Work through these before you decide Mounjaro is not working:

  • Timing of the A1C. An A1C reflects about 3 months of blood sugar. A test drawn 6 weeks after you start mixes old and new data.
  • Home readings. Fasting and after-meal glucose readings over 2 to 3 weeks often show a trend before the next A1C does.
  • Other medicines. If you also take insulin or a sulfonylurea, your prescriber may lower those to prevent low blood sugar. That is a planned change, and it can make total control look different for a while.
  • Illness and steroids. An infection or a course of steroids can raise blood sugar for weeks. Tell your prescriber about either.
  • Missed doses. Gaps let blood sugar rise again.

Practical problems that weaken the effect

Many "not working" cases come from the routine, not from the drug.

Missed doses. The label gives a 4-day (96-hour) window to take a missed dose, and it says what to do after that window. It also says two doses must be at least 3 days (72 hours) apart if your dose day changes. Ask your pharmacist if you are not sure which rule applies to you. See missed GLP-1 dose.

Storage. Keep Mounjaro in the refrigerator at 36°F to 46°F, and do not freeze it. A single-dose pen or vial can be kept unrefrigerated up to 86°F for a total of 21 days. A multi-dose pen has its own limits in the instructions. If a pen froze or got hot, ask your pharmacist before you use it. See GLP-1 left out of the fridge.

Injection problems. Inject under the skin of the stomach or thigh, or have another person inject the back of the upper arm, and rotate sites. If the pen does not seem to deliver a full dose, read Mounjaro KwikPen not working and injection technique.

Compounded tirzepatide. The FDA has not approved compounded tirzepatide. It has received hundreds of adverse event reports linked to compounded tirzepatide, some of which may relate to doses beyond the approved label. If your product changed and your results changed, tell your prescriber exactly what you use.

One interaction to know: oral birth control

Mounjaro slows how fast the stomach empties. The label says this can lower how well oral hormonal birth control works, and that the effect is largest after the first dose. It advises people who use oral contraceptives to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. This is not a sign that Mounjaro is not working. It is a sign that Mounjaro is working on your stomach, and it is worth a question to your prescriber or pharmacist.

When and how to talk to your prescriber

Book a visit if:

  • You have spent about 3 months on a dose and your A1C has not changed.
  • Your blood sugar was improving, and it is now rising on the same dose.
  • Side effects are keeping you from the next step or from keeping your current dose.
  • Weight is your main goal and you want to discuss whether another product fits you better.

Bring:

  1. The date and dose of each injection, and any missed weeks.
  2. Home glucose readings and your last A1C dates.
  3. A weight trend if weight matters to you.
  4. Side effects, with how severe they were.

Your prescriber can then decide whether to give it more time, move up a step, add or change other diabetes medicines, or try something else. If you came to Mounjaro from semaglutide, switching semaglutide to tirzepatide covers what usually changes.

Warning signs that need care now

Get medical care right away for:

  • Severe stomach pain that does not go away, with or without vomiting.
  • Upper right belly pain, fever, yellow skin or eyes, or clay-colored stool.
  • Swelling of the face, lips, tongue, or throat, trouble breathing, or a severe rash.
  • Signs of low blood sugar, such as shaking, sweating, confusion, or a fast heartbeat.
  • Vomiting or diarrhea that stops you from keeping fluids down.
  • A sudden decrease or loss of vision in one eye.
  • A lump in the neck, trouble swallowing, or lasting hoarseness.

Mounjaro®, Zepbound®, KwikPen® are trademarks of Eli Lilly and Company. Vital is independent and not affiliated with these companies.

Free toolGLP-1 medication level chart

Things to watch

Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.

  • Judging Mounjaro on the 2.5 mg start

    The label starts at 2.5 mg and raises the dose by 2.5 mg no sooner than every 4 weeks. Reaching 15 mg takes about 20 weeks at the fastest pace.

  • Expecting the 15 mg weight result on a lower dose

    In the label trials, weight loss grew with dose. A person on 5 mg should compare to the 5 mg result, not the 15 mg result.

  • Missed doses past 4 days

    The label gives a 4-day window to take a missed dose. Repeated gaps let blood sugar and hunger rise again.

  • Relying on oral birth control after a dose change

    Mounjaro can lower how well oral contraceptives work. The label advises a non-oral or added barrier method for 4 weeks after starting and after each dose increase.

  • Pens kept warm too long

    Single-dose pens and vials can stay unrefrigerated up to 86°F for a total of 21 days. Ask your pharmacist before you use a pen that froze or got too warm.

  • Sudden vision loss in one eye

    The label added NAION, a sudden decrease or loss of vision in one eye, as a reported problem with GLP-1 drugs. Get eye care right away.

Frequently asked questions

  • Mounjaro starts at 2.5 mg and can go up by 2.5 mg after at least 4 weeks on each dose. An A1C reflects about 3 months of blood sugar, so the clearest check comes after a few months on a steady dose. Home glucose readings can show a trend sooner.

  • Common reasons are a low current dose, missed doses, and expectations based on higher doses or on Zepbound weight trials. In the label trial of Mounjaro alone, weight loss was about 6.3 to 7.8 kg over 40 weeks depending on dose. Ask your prescriber how your dose and goals fit.

  • The 2.5 mg dose is the starting dose that helps your body adjust. Some people notice less hunger on it, but the label plans dose increases if more blood sugar control is needed.

  • Check for missed doses, pen storage problems, illness, or new medicines first. Then bring your dose history, glucose readings, and weight trend to your prescriber, who can decide on the next step. Do not raise your dose on your own.

  • In the label's 40-week head-to-head trial, Mounjaro 5 to 15 mg lowered A1C and weight more on average than semaglutide 1 mg. Individual results vary, and the right choice depends on your health, coverage, and side effects.

  • The label gives a 4-day (96-hour) window to take a missed dose and says what to do after that. If you are not sure which rule applies, ask your pharmacist or prescriber before your next dose.

Sources

  1. MOUNJARO (tirzepatide) injection Prescribing Information · Eli Lilly and Company
  2. How to Use, Dosing & Side Effects | Mounjaro · Eli Lilly and Company
  3. Tirzepatide (subcutaneous route) · Mayo Clinic
  4. The A1C Test & Diabetes · NIDDK, National Institutes of Health
  5. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration

This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.

Track every shot, every change

Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.